|
|||||
|
|
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study |
|
| Authors: | Parikh Asit Leach Timothy Wyant Tim Scholz Catherine Sankoh Serap Mould Diane R Ponich Terry Fox Irving Feagan Brian G |
| Affiliation: | Millennium: A Takeda Company, Cambridge, Massachusetts, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |